The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing the cost-effectiveness of immunotherapy strategies in BRAF wild-type advanced melanoma.
Simon B. Zeichner
No Relationships to Disclose
Christine Kohn
No Relationships to Disclose
Qiushi Chen
No Relationships to Disclose
Daniel A. Goldstein
No Relationships to Disclose
Alberto J. Montero
No Relationships to Disclose
Christopher Flowers
Consulting or Advisory Role - OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences